News
J&J faces talc lawsuits from more than 62,000 plaintiffs, according to a company filing. But the figure swells as high as 100,000 when counting claimants who haven't sued, Erik Haas, J&J's global ...
J&J faces talc lawsuits from more than 62,000 plaintiffs, according to a company filing. But the figure swells as high as 100,000 when counting claimants who haven't sued, Erik Haas, J&J's global ...
J&J faces talc lawsuits from more than 62,000 plaintiffs, according to a company filing. But the figure swells as high as 100,000 when counting claimants who haven’t sued, Erik Haas, J&J’s ...
Hosted on MSN7mon
J&J’s $8.2 Billion Talc Settlement Faces January Court Test - MSNJ&J has struggled to end the 15-year-long litigation over its talc-based baby powder, which the company insists never caused cancer and is no longer available.
J&J is reported to have raised its offer to settle claims that its talc products caused cancer by $1.1bn, as it reaches agreement with a holdout law firm.
J&J’s Red River Talc unit made its filing in the U.S. Bankruptcy Court for the Southern ... any settlement J&J reached with some claimants would still leave holdouts or future plaintiffs ...
Johnson & Johnson is reportedly nearing enough support to finalize a $6.5 billion settlement for lawsuits related to cancer cases linked to its baby powder and other talc products.
A federal judge in Houston has rejected the third attempt by Johnson & Johnson’s (J&J) subsidiary Red River to settle thousands of lawsuits related to its talc-based products, which have been ...
RELATED: Johnson & Johnson talc settlement includes $15M for MD; first payment due late July. Last year a subsidiary of J&J proposed to pay approximately $6.48 billion over 25 years as part of a ...
NEW YORK, Aug 14 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab is preparing to unveil widespread support in coming days for a $6.48 billion offer to settle tens of thousands of legal ...
J&J Has Enough Support From Claimants for $6.5-Billion Talc Settlement, Bloomberg Reports By Dietrich Knauth NEW YORK (Reuters) -Johnson & Johnson has cleared a key threshold of support for its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results